Literature DB >> 15512905

Temporal gene expression patterns in G93A/SOD1 mouse.

Ling-Chun Chen1, Andrew Smith, Yong Ben, Belma Zukic, Sheila Ignacio, Dan Moore, Nancy Lee.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a generally fatal degenerative disorder of motor neurons that has no known cure. Many pathological processes have been implicated. However, the early, initiating events in the disease are poorly understood. We performed multivariate analyses of gene expression of 21 selected genes from categories including glutamate neurotoxicity, oxidative stress, neuroinflammation, aberrant metal ion regulation, apoptosis, and abnormal microglial function on G93A SOD1 mice. These animals develop symptoms of motor neuron dysfunction at about 12 weeks of age, and die at age 18 to 20 weeks. We analyzed animals at both presymptomatic and symptomatic stages. Differential regulation of several genes involved in neuroinflammation, including TNF-alpha, IL- RA, CD86, CD200R and Groalpha, was observed in presymptomatic mice, aged 6-9 weeks, while expression of genes representative of other processes was not altered until the animals reached symptomatic stages. Analysis of expression of inflammatory genes and microglia related genes together also revealed a highly significant change in mutant mice relative to wildtype at 6-9 weeks. These changes were due to the presence of the mutant gene, and not simply to overexpression of a SOD1 gene. These findings are discussed in relation to possible roles of microglia function in the development of ALS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512905     DOI: 10.1080/14660820410017091

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  14 in total

1.  Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1.

Authors:  Siranush A Sargsyan; Daniel J Blackburn; Siân C Barber; Peter N Monk; Pamela J Shaw
Journal:  Neuroreport       Date:  2009-10-28       Impact factor: 1.837

2.  Impact of peripheral immune status on central molecular responses to facial nerve axotomy.

Authors:  D O Setter; E M Runge; N D Schartz; F M Kennedy; B L Brown; K P McMillan; W M Miller; K M Shah; M M Haulcomb; V M Sanders; K J Jones
Journal:  Brain Behav Immun       Date:  2017-10-10       Impact factor: 7.217

3.  Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates.

Authors:  Melissa M Haulcomb; Nichole A Mesnard-Hoaglin; Richard J Batka; Rena M Meadows; Whitney M Miller; Kathryn P Mcmillan; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2015-06-22       Impact factor: 3.215

Review 4.  Could Sirtuin Activities Modify ALS Onset and Progression?

Authors:  Bor Luen Tang
Journal:  Cell Mol Neurobiol       Date:  2016-12-10       Impact factor: 5.046

5.  Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.

Authors:  Pingwei Zhao; Sheila Ignacio; Eric C Beattie; Mary E Abood
Journal:  Eur J Neurosci       Date:  2008-02       Impact factor: 3.386

6.  Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.

Authors:  Melissa M Haulcomb; Nichole A Mesnard; Richard J Batka; Thomas D Alexander; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2014-07-01       Impact factor: 3.215

Review 7.  The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-06-20       Impact factor: 5.590

8.  In Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS.

Authors:  Payam Dibaj; Heinz Steffens; Jana Zschüntzsch; Fabien Nadrigny; Eike D Schomburg; Frank Kirchhoff; Clemens Neusch
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

9.  Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation.

Authors:  Kenneth Hensley; Haitham Abdel-Moaty; Jerrod Hunter; Molina Mhatre; Shenyun Mou; Kim Nguyen; Tamara Potapova; Quentin N Pye; Min Qi; Heather Rice; Charles Stewart; Katharine Stroukoff; Melinda West
Journal:  J Neuroinflammation       Date:  2006-01-25       Impact factor: 8.322

Review 10.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.